<DOC>
	<DOCNO>NCT01632267</DOCNO>
	<brief_summary>Antidepressants among widely prescribe medication , yet 35-45 % patient achieve remission follow initial antidepressant trial . The financial burden treatment failure direct treatment cost , disability , decrease productivity , miss work may part derive mismatch optimal , actual , medication prescribe . The present one year retrospective study seek evaluate indirect direct healthcare cost 96 patient DSM-IV-TR depressive anxiety disorder , relation interpretive reporting system design predict antidepressant response base DNA variation cytochrome P450 gene ( CYP2D6 , CYP2C19 , CYP1A2 ) , serotonin transporter gene ( SLC6A4 ) , serotonin 2A receptor ( 5HTR2A ) gene .</brief_summary>
	<brief_title>Retrospective Analysis Outcomes With Pharmacogenomic Algorithm</brief_title>
	<detailed_description />
	<criteria>Major Depressive Disorder Dysthymic Disorder Depressive Disorder NOS Obsessive Compulsive Disorder ( OCD ) Generalized Anxiety Disorder Panic Disorder Anxiety Disorder NOS PostTraumatic Stress Disorder ( PTSD ) Social Phobia Bipolar Disorder Schizophrenia Schizoaffective Disorder Previous pharmacogenomic testing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>